Coming Soon

Dual GLP-1/glucagon receptor co-agonist peptide.

Long-acting amylin analogue, amylin receptor agonist.

GLP-1/glucagon receptor co-agonist peptide.

Reduced-concentration BPC-157 / GHK-Cu / TB-500 blend.

Pentadecapeptide / Thymosin Beta-4 analogue two-peptide blend.

GHRH analogue / ghrelin mimetic combination blend.

Synthetic pentadecapeptide, nitric oxide and GH receptor modulator.

Synthetic Thymosin Beta-4 analogue, actin-sequestering peptide.

Thymic polypeptide fraction, T-cell regulatory bioregulator.

Mitochondria-targeted cardiolipin-binding tetrapeptide.

AMPK activator, cell-permeable AMP kinase agonist.

Cathelicidin-related antimicrobial peptide, immunomodulatory.

Synthetic tetrapeptide Ala-Glu-Asp-Gly, telomerase activator.

D-retro-inverso peptide, FOXO4-p53 interaction disruptor.

28-amino acid thymic peptide, TLR signaling modulator.

Mitochondrial 12S rRNA-encoded peptide, AMPK signaling activator.

Modified GRF(1-29), short-acting GHRH receptor agonist.

Selective ghrelin receptor agonist, growth hormone secretagogue.

Synthetic hexapeptide ghrelin receptor agonist, potent GH secretagogue.

First-generation hexapeptide ghrelin mimetic, GHSR-1a agonist.

High-potency synthetic hexapeptide GHSR-1a and CD36 ligand.

Long R3 IGF-1 analogue with reduced IGFBP binding affinity.

Des(1-3)IGF-1, truncated IGF-1 analogue with no IGFBP binding.

IGF-1 Ec splice variant, mechano-sensitive satellite cell activator.

PEGylated Mechano Growth Factor with extended plasma half-life.

HGH lipolytic domain fragment, amino acids 176–191.

TGF-β superfamily member, negative regulator of skeletal muscle mass.

TGF-β superfamily antagonist, myostatin and activin neutralizer.

ACTH(4-10)-derived synthetic heptapeptide, BDNF upregulator.

Synthetic tuftsin analogue, GABA-A receptor modulator.

Delta Sleep-Inducing Peptide, nonapeptide neuromodulator.

Pineal tripeptide Glu-Asp-Arg, circadian gene expression modulator.

α-MSH C-terminal tripeptide Lys-Pro-Val, MC1R anti-inflammatory fragment.

Decapeptide KISS1 fragment, GPR54/KISS1R agonist.

Acetyl Glutamyl Heptapeptide-3, SNARE complex modulator.

p53 HDM-2-binding domain peptide, cancer cell membrane disruptor.

Small molecule NNMT inhibitor, SAM-dependent methyltransferase blocker.

Chimeric proapoptotic peptide targeting white adipose tissue vasculature.

Heptapeptide μ-opioid receptor agonist containing D-alanine.

ActRIIB-Fc fusion protein, myostatin/activin ligand trap.

Synthetic ERRα/β/γ pan-agonist, exercise-mimetic transcription activator.

Synthetic GnRH decapeptide, GnRH receptor agonist.

28-amino acid vasoactive neuropeptide, VPAC1/VPAC2 receptor agonist.